Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May, 2024
Outcome of Board Meeting held on 6th May, 202406-05-2024
06-05-2024
Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations, 2015, we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday, 2nd May, 2024 which commenced at 2:00 P.M., and Concluded at 7:30 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, has decided to Re-schedule the meeting to be held on 6th May, 2024 for discuss and consider, inter-alia: ? The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. ? The proposal of sub-division of equity shares of the Company. ? The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. Note that meeting is reschedule due to requirement of expert advice.02-05-2024
Dipna Pharmachem Ltd - 543594 - Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Statement on Deviation or Variation of funds under Regulation 32 of SEBI (LODR) Regulations, 2015.01-05-2024
Dipna Pharmachem Ltd - 543594 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015.27-04-2024
Dipna Pharmachem Ltd - 543594 - Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Submission of Certificate under Regulation 40(9) read with Regulation 40(10) of SEBI (LODR) Regulations, 2015 for the financial year ended on 31st March, 2024.26-04-2024
Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 26Th April, 2024 To 2Nd May, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday, 26th April, 2024 at 2:00 P.M., is now rescheduled to Thursday, 2nd May, 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. 3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis.25-04-2024
Dipna Pharmachem Ltd - 543594 - Update on board meeting
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that in continuation to the intimation submitted on 8th April, 2023 vide Acknowledgement No.: 7079374 to the Exchange, in the meeting of the Board of Directors of the Company which will be held on Friday, 26th April, 2024 at 2:00 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis shall also be placed for discussion and consideration. Further, this intimation is submitted to the reference of Board meeting held will be held on 26th April, 2024 and the link of the earlier announcement is https://www.bseindia.com/xmldata/ corpfiling/AttachHis/f00282ab-9375-4f0b-bd73 2463d3c5554b.pdf22-04-2024
Dipna Pharmachem Ltd - 543594 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Sevantilal Shah18-04-2024
Dipna Pharmachem Ltd - 543594 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nishil Financial Advisors LLP18-04-2024
Dipna Pharmachem Ltd - 543594 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Shah18-04-2024